Connect with us
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

News

Medidata Recognized as the Only Company to be Both a Leader and Star Performer in Everest Group’s 2019 Life Sciences Clinical Trials Products PEAK Matrix™

gbafNews28

Medidata (NASDAQ:MDSO) announced today that it has been named a Leader in the Everest Groups 2019 Life Sciences Clinical Trials Products PEAK Matrix, based upon market impact, plus vision and capability. Medidata was also recognized as a Star Performer, which designates the greatest positive relative year-on-year movement on the PEAK Matrix.

Were thrilled to be the only company to be designated both a leader and star performer, said Glen de Vries, president and co-founder, Medidata.

Everest Group noted that as a leader, Medidata has established itself as a front runner to support life science firms looking to achieve digital transformation within clinical trials. The report notes that leaders have showcased:

  • An integrated end-to-end platform offering for processes across the complete clinical trial
  • A healthy mix of mid-and large-sized clientele, with accounts in many prominent life science firms
  • Technological expertise and the ability to incorporate digital technology themes within their products
  • Consulting pedigree to add to strong product functionality

“The clinical trials landscape has a significant opportunity for digitalization focused on enhancing trial efficiency, optimizing costs, and reducing cycle time to get drugs to market faster. Currently, most life sciences firms use disparate point solutions for different functions across their clinical trials. Medidata is ramping up Rave and enhancing its portfolio through Acorn AI and SHYFT. Its focus on enabling an intelligent platform underpinned by AI positions it well to partner with life sciences enterprises on this journey, said Nitish Mittal, Practice Director at Everest Group.

There are five distinguishing features which Everest Group identified which make Medidata a Star Performer in this years report:

  • Introduction of Acorn AI, a platform incorporating digital technology themes to enhance clinical trials
  • Building upon its reputation for being a leading vendor in the market for EDC solutions
  • High market adoption for data capture and Rave
  • Enterprise that began with only EDC solutions are expanding and opening up to other Medidata products/solutions and expanding the engagement
  • Consulting pedigree and effort invested in understanding customers business

This designation is a reflection of our strong business mission and the uniquely qualified expertise of our people for bringing an innovative and game-changing solution to market. Medidata is leading the digital transformation of clinical trials. Its all about the patients and getting treatments to them as fast and as safely as possible, said de Vries.

The Medidata Rave Clinical Cloud„¢ is the cutting-edge platform that transforms the clinical trial experience for patients, sponsors, CROs, and research sites. Medidata Rave Clinical Cloud accelerates the business of clinical research with an end-to-end suite of Rave applications for Data Capture, Data Management, Trial Planning, Trial Management, and Analytics powered by a rich set of Platform Tools.

About Medidata:

Medidata is leading the digital transformation of life sciences, with the world’s most-used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by top ranked industry experts, Medidata helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata and its companies, Acorn AI and SHYFT, serve more than 1,200 customers and partners worldwide and empower more than 150,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.medidata.com

Medidata Solutions:
Investors:
Betsy
Frank, 917-522-4620
bfrank@medidata.com
or
Media:
Erik
Snider, 646-362-2997
esnider@medidata.com

Advertisement
Editorial & Advertiser disclosure

Call for Entries

Global Banking and Finance Review Awards Nominations 2022
2022 Awards now open. Click Here to Nominate

Newsletters with Secrets & Analysis. Subscribe Now

Recommended

Global Banking & Finance Review® is a leading financial portal and Print Magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management. Copyright © 2010-2021 GBAF Publications Ltd - All Rights Reserved.